Delaware judge reassigns Elon Musk cases after accusation of bias

Judge Kathaleen McCormick denied Elon Musk's recusal motion but reassigned three Musk-related matters from the Delaware Court of Chancery to other judges. The LinkedIn post at issue touted a verdict that could cost Musk upwards of $2 billion; McCormick previously ordered Tesla to rescind Musk's 2018 pay package (about $56 billion in options), a decision later overturned by Delaware's Supreme Court in 2025. Two Delaware cases remain active: one on Tesla directors' compensation and a consolidated shareholder suit alleging Musk breached fiduciary duties by starting a potential AI competitor, xAI.

Analysis

High‑profile governance litigation creates a persistent volatility premium priced into Tesla equity beyond near‑term fundamental drivers. Even absent immediate adverse rulings, a plausible 50–150bp rise in Tesla’s equity risk premium over 12–24 months would mechanically shave mid‑single‑digit to low‑teens percent off enterprise valuations for long‑duration cash flow models, because the company’s growth is valued far out the curve.

Forum‑shopping and repeated headline risk raise second‑order costs that aren’t on the P&L today: D&O insurers will re‑price pockets of exposure, directors will demand higher retainer/indemnity terms, and strategic counterparties will require stronger contractual protections. Expect D&O premium inflation of 20–40% for companies with Musk‑style concentrated control profiles over the next 12–24 months, which translates to higher cash outflows (or higher hurdle rates) for deals and executive comp packages.

Market microstructure angle — litigation milestones (motions, hearings, appeal decisions) create short, tradable volatility spikes that recur over months-to-years. That dynamic favors defined‑risk option structures and disciplined pair trades that isolate governance premium from underlying EV demand and margin trajectories; passive long/short exposure to auto peers or insurers offers cleaner ways to capture the governance re‑pricing without betting on product cycles.

Key Decisions for Investors

• Hedge asymmetric downside in TSLA via a 9–15 month put spread: buy 1x 25% OTM put and sell 1x 45% OTM put (rollable, defined‑risk). Rationale: caps premium while protecting against a governance‑driven >30% drawdown; max loss = premium paid, max gain = spread width minus premium. Target allocation: 1–2% of portfolio.
• Trade event volatility by selling short‑dated (30–45 day) straddles only after IV >80% and with capped exposure: hedge tails with 1–2% notional of far OTM protective wings. Timeframe: tactical, reset around each litigation milestone. Risk: significant gap moves — use strict size limits and buy protection if IV falls.
• Long D&O/insurer exposure (TRV, AIG) 6–18 months: thesis is accelerating premium pricing and improved underwriting margins. Position size: 1–3% each; upside target 10–25% with stop loss -12% if broad credit/insurance cycles turn.
• Pair trade to isolate governance risk: short TSLA equity (size X) and go long GM (or another high‑governance OEM) at ~60% notional to neutralize auto cycle exposure. Timeframe 6–12 months; cut losses if pair performance diverges >15% due to idiosyncratic business news.